Recursion Pharmaceuticals faces a 57% stock drop amid drug setbacks, rising cash burn, and AI discovery doubts.

There’s a huge amount of financing required to close the financing gap on the continent,” noted Taiwo Okwor, Vice President ...

Policymakers are increasingly focused on reforming prior authorization to reduce administrative burdens and improve patient ...